--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q2850.000K / 0.000--
MARA Holdings
MARA
Ecopetrol
EC
Oracle
ORCL
NVIDIA
NVDA
Apple
AAPL
US Stock MarketDetailed Quotes
CMPX Compass Therapeutics
- 2.690
- +0.070+2.67%
Close Mar 7 16:00 ET
- 2.690
- 0.0000.00%
Post 20:01 ET
371.98MMarket Cap-7.47P/E (TTM)
2.790High2.600Low573.75KVolume2.610Open2.620Pre Close1.54MTurnover0.69%Turnover RatioLossP/E (Static)138.28MShares4.08052wk High2.97P/B224.95MFloat Cap0.76552wk Low--Dividend TTM83.63MShs Float8.800Historical High--Div YieldTTM7.25%Amplitude0.765Historical Low2.682Avg Price1Lot Size
Compass Therapeutics Key Stats
Compass Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Compass Therapeutics Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data